Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review

Triple-negative breast cancer (TNBC), which represents 15%–20% of all breast cancers, is defined by the absence of estrogen receptor (ER) and progesterone receptor (PR) and overexpression of human epidermal growth factor receptor 2 (HER2). Owing to the absence of specific therapeutic targets and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fengxia, Pu, Feifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388262/
https://www.ncbi.nlm.nih.gov/pubmed/28435291
http://dx.doi.org/10.2147/OTT.S123803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388262/
https://www.ncbi.nlm.nih.gov/pubmed/28435291
http://dx.doi.org/10.2147/OTT.S123803

Ejemplares similares